Target volume delineation of anal cancer based on magnetic resonance imaging or positron emission tomography

about

Target volume delineation of anal cancer based on magnetic resonance imaging or positron emission tomography

Item

http://www.wikidata.org/entity/Q41625221

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Target volume delineation of a ...... r positron emission tomography

@en

type

Item

label

Target volume delineation of a ...... r positron emission tomography

@en

prefLabel

Target volume delineation of a ...... r positron emission tomography

@en

P1476

Target volume delineation of a ...... r positron emission tomography

@en

P2093

Bernt Louni Rekstad

http://www.w3.org/2001/XMLSchema#string

Bettina Hanekamp

http://www.w3.org/2001/XMLSchema#string

Christine Undseth

http://www.w3.org/2001/XMLSchema#string

Eivor Hernes

http://www.w3.org/2001/XMLSchema#string

Espen Rusten

http://www.w3.org/2001/XMLSchema#string

Ghazwan Al-Haidari

http://www.w3.org/2001/XMLSchema#string

Marianne Grønlie Guren

http://www.w3.org/2001/XMLSchema#string

Taran Paulsen Hellebust

http://www.w3.org/2001/XMLSchema#string

P2860

Phase I study of cetuximab in combination with 5-fluorouracil, mitomycin C and radiotherapy in patients with locally advanced anal cancer.

Impaired health-related quality of life after chemoradiotherapy for anal cancer: late effects in a national cohort of 128 survivors.

FDG-PET/CT imaging for staging and target volume delineation in conformal radiotherapy of anal carcinoma.

RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal

Adaptive and innovative Radiation Treatment FOR improving Cancer treatment outcomE (ARTFORCE); a randomized controlled phase II trial for individualized treatment of head and neck cancer

Multiparametric MRI as an outcome predictor for anal canal cancer managed with chemoradiotherapy.

Critical discussion of evaluation parameters for inter-observer variability in target definition for radiation therapy.

Australasian Gastrointestinal Trials Group (AGITG) contouring atlas and planning guidelines for intensity-modulated radiotherapy in anal cancer.

Current treatment of anal squamous cell carcinoma.

The Role of FDG-PET in the Initial Staging and Response Assessment of Anal Cancer: A Systematic Review and Meta-analysis.

P2888

s13014-017-0883-z

P304

147

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13014-017-0883-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Eirik Malinen

P577

2017-09-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1091486825

http://www.w3.org/2001/XMLSchema#string

P698

28874205

http://www.w3.org/2001/XMLSchema#string

P932

5585969

http://www.w3.org/2001/XMLSchema#string